Literature DB >> 19403908

A step forward in therapy for hepatitis C.

Jay H Hoofnagle.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19403908     DOI: 10.1056/NEJMe0901869

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.

Authors:  Ann D Kwong; Robert S Kauffman; Patricia Hurter; Peter Mueller
Journal:  Nat Biotechnol       Date:  2011-11-08       Impact factor: 54.908

2.  The next era of HCV antiviral therapy finally begins: part 2.

Authors:  David Bobak
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

3.  Hepatitis C virus transmission bottlenecks analyzed by deep sequencing.

Authors:  Gary P Wang; Scott A Sherrill-Mix; Kyong-Mi Chang; Chris Quince; Frederic D Bushman
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  The next era of HCV antiviral therapy finally begins: part 1.

Authors:  David Bobak
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.663

5.  Treatment of hepatitis C infections with interferon: a historical perspective.

Authors:  Robert M Friedman; Sara Contente
Journal:  Hepat Res Treat       Date:  2010-09-06

6.  Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.

Authors:  Libin Rong; Alan S Perelson
Journal:  Math Biosci       Date:  2013-05-16       Impact factor: 2.144

Review 7.  Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b.

Authors:  Graham R Foster
Journal:  Drugs       Date:  2010       Impact factor: 9.546

8.  Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation.

Authors:  Takeshi Yoshikawa; Akemi Takata; Motoyuki Otsuka; Takahiro Kishikawa; Kentaro Kojima; Haruhiko Yoshida; Kazuhiko Koike
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

9.  Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.

Authors:  Hui Li; Mark B Stoddard; Shuyi Wang; Lily M Blair; Elena E Giorgi; Erica H Parrish; Gerald H Learn; Peter Hraber; Paul A Goepfert; Michael S Saag; Thomas N Denny; Barton F Haynes; Beatrice H Hahn; Ruy M Ribeiro; Alan S Perelson; Bette T Korber; Tanmoy Bhattacharya; George M Shaw
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

10.  Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.

Authors:  Libin Rong; Jeremie Guedj; Harel Dahari; Daniel J Coffield; Micha Levi; Patrick Smith; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2013-03-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.